BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36652464)

  • 1. Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study.
    Lindberg BF; Nelson I; Ranstam J; Riker DK
    PLoS One; 2023; 18(1):e0279204. PubMed ID: 36652464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial.
    Lindberg F; Nelson I; Ranstam J; Riker DK
    PLoS One; 2022; 17(7):e0270699. PubMed ID: 35789217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ColdZyme® Mouth Spray on prevention of upper respiratory tract infections in a boy with primary immunodeficiency: a case report.
    Clarsund M; Blom U; Gardulf A
    J Med Case Rep; 2016 Oct; 10(1):302. PubMed ID: 27799071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions.
    Davison G; Perkins E; Jones AW; Swart GM; Jenkins AR; Robinson H; Dargan K
    Eur J Sport Sci; 2021 May; 21(5):771-780. PubMed ID: 32419645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial.
    Eccles R; Winther B; Johnston SL; Robinson P; Trampisch M; Koelsch S
    Respir Res; 2015 Oct; 16():121. PubMed ID: 26438038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
    Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
    J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.
    Mukherjee PK; Esper F; Buchheit K; Arters K; Adkins I; Ghannoum MA; Salata RA
    BMC Infect Dis; 2017 Jan; 17(1):74. PubMed ID: 28088167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Trypsin Oral Spray (Viruprotect
    Huijghebaert S; Vanham G; Van Winckel M; Allegaert K
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34064793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold.
    Hagen M; Clark K; Kalita P; Serra G; Sanchez E; Varbiro G; Albasser MM
    Ther Adv Respir Dis; 2024; 18():17534666241228927. PubMed ID: 38372128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.
    Hayden FG; Turner RB; Gwaltney JM; Chi-Burris K; Gersten M; Hsyu P; Patick AK; Smith GJ; Zalman LS
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3907-16. PubMed ID: 14638501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial.
    Ludwig M; Enzenhofer E; Schneider S; Rauch M; Bodenteich A; Neumann K; Prieschl-Grassauer E; Grassauer A; Lion T; Mueller CA
    Respir Res; 2013 Nov; 14(1):124. PubMed ID: 24219370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold.
    Fazekas T; Eickhoff P; Pruckner N; Vollnhofer G; Fischmeister G; Diakos C; Rauch M; Verdianz M; Zoubek A; Gadner H; Lion T
    BMC Complement Altern Med; 2012 Sep; 12():147. PubMed ID: 22950667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial.
    Hayden FG; Diamond L; Wood PB; Korts DC; Wecker MT
    Ann Intern Med; 1996 Jul; 125(2):89-97. PubMed ID: 8678385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
    Posch W; Vosper J; Zaderer V; Noureen A; Constant S; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
    mBio; 2021 Apr; 12(2):. PubMed ID: 33906927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study.
    Henneicke-von Zepelin H; Hentschel C; Schnitker J; Kohnen R; Köhler G; Wüstenberg P
    Curr Med Res Opin; 1999; 15(3):214-27. PubMed ID: 10621929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of 0.5% Carbomer 980 Gel for Treatment of Symptoms of Common Cold: Results of 2 Randomized Trials.
    Dennie L
    Drugs R D; 2019 Jun; 19(2):191-200. PubMed ID: 31004286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal pirodavir (R77,975) treatment of rhinovirus colds.
    Hayden FG; Hipskind GJ; Woerner DH; Eisen GF; Janssens M; Janssen PA; Andries K
    Antimicrob Agents Chemother; 1995 Feb; 39(2):290-4. PubMed ID: 7726484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial.
    Goel V; Lovlin R; Barton R; Lyon MR; Bauer R; Lee TD; Basu TK
    J Clin Pharm Ther; 2004 Feb; 29(1):75-83. PubMed ID: 14748902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a single evening dose of syrup containing paracetamol, dextromethorphan hydrobromide, doxylamine succinate and ephedrine sulfate in subjects with multiple common cold symptoms.
    Mizoguchi H; Wilson A; Jerdack GR; Hull JD; Goodale M; Grender JM; Tyler BA
    Int J Clin Pharmacol Ther; 2007 Apr; 45(4):230-6. PubMed ID: 17474541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.